NASDAQ: PASWPing An Biomedical Co Revenue
Ping An Biomedical Co revenue was $11.99M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Sep 30, 2024, PASW annual revenue was $12.3M, with 8.4% growth year-over-year.
PASW past revenue growth
How has PASW's revenue growth performed historically?
Company
8.36%
Industry
-5.09%
Market
19.55%
PASW's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PASW's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PASW's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
PASW revenue history
Current Revenue
$12.3M
Current Earnings
-$180.4k
Current Profit Margin
-1.5%
Be the first to know when PASW announces revenue.
PASW Revenue History By Year
| PASW Yearly Revenue | PASW Revenue | PASW Change | PASW Revenue Growth |
|---|---|---|---|
| 2024-09-30 | $12.31M | $949.74k | +8.36% |
| 2023-09-30 | $11.36M | -$4.55M | -28.62% |
| 2022-09-30 | $15.91M | $479.78k | +3.11% |
| 2021-09-30 | $15.43M | N/A | N/A |
Ping An Biomedical Co Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.